Buy Tirzepatide in South Africa
Tirzepatide is a dual GIP and GLP-1 receptor agonist. SURMOUNT-1 demonstrated 20.9% mean body weight reduction at 72 weeks — the largest in any Phase 3 obesity trial at time of publication. QSC ships internationally to South Africa in 8–12 business days. South Africa is Africa's premier biomedical research market — UCT, Wits, Stellenbosch, Aspen Pharmacare, and the world's largest ART programme all generate sophisticated research demand in GIP/GLP-1 Dual Agonist and related areas.
Tirzepatide (CAS 2023788-19-2): Tirzepatide (CAS 2023788-19-2, 39-amino acid peptide) activates both GIPR and GLP-1R simultaneously. Dual agonism produces additive insulin secretion, enhanced beta-cell function, and greater hypothalamic appetite suppression vs GLP-1 monotherapy. Half-life approximately 5 days. QSC supplies research-grade Tirzepatide at >=99% HPLC purity, Janoshik COA. Order at qscpeptide.com.
Buy Tirzepatide — International Shipping to South Africa
R1,147 / USD 62 · 8–12 business days · Free shipping · >=99% HPLC, Janoshik COA. Bitcoin and USDT.
Buy Tirzepatide at QSC →South Africa Shipping Details
| Province | Delivery Time |
|---|---|
| Gauteng (Johannesburg, Pretoria) | 8–12 business days |
| Western Cape (Cape Town, Stellenbosch) | 8–12 business days |
| KwaZulu-Natal (Durban) | 8–12 business days |
| Eastern Cape, Free State, Mpumalanga | 10–14 business days |
| Limpopo, North West, Northern Cape | 10–16 business days |
| Tracking number | All orders |
| Shipping cost | Free |
| Purity | >=99% HPLC |
| COA | Janoshik (independent) |
| Payment | Bitcoin / USDT |
| Pricing | ZAR (R) and USD listed |
Mechanism of Action
Tirzepatide (CAS 2023788-19-2, 39-amino acid peptide) activates both GIPR and GLP-1R simultaneously. Dual agonism produces additive insulin secretion, enhanced beta-cell function, and greater hypothalamic appetite suppression vs GLP-1 monotherapy. Half-life approximately 5 days.
Tirzepatide — Research Data
SURMOUNT-1 (NCT04184622): 20.9% weight reduction at 72 weeks. SURPASS-2 vs semaglutide: superior on both HbA1c and weight. South Africa has one of the highest rates of type 2 diabetes in sub-Saharan Africa — approximately 12.7% of adults (IDF 2024) — making dual incretin agonist research highly relevant to UCT, Wits, and UKZN clinical pharmacology programmes.
Available Nationwide
QSC ships Tirzepatide internationally to all 9 South African provinces: Gauteng (Johannesburg, Pretoria/Tshwane), Western Cape (Cape Town, Stellenbosch), KwaZulu-Natal (Durban), Eastern Cape (Gqeberha, East London), Free State (Bloemfontein), Mpumalanga, Limpopo, North West, and Northern Cape. Key institutions — UCT, Wits, Stellenbosch University, UP, SAMRC, Aspen Pharmacare, KBC facilities — all within the delivery network. ZAR (R) and USD pricing shown. Payment: Bitcoin (BTC) and USDT/USDC only.